Supporting Taligen’s efforts is a Scientific Advisory Board featuring renowned experts in the field of complement system biology and the development of novel protein therapeutics.

Michael Holers, M.D., Taligen Chief Scientific Officer and co-founder

John Atkinson, M.D.: Dr. Atkinson is currently Samuel B. Grant professor of medicine and professor in molecular microbiology and medicine at Washington University School of Medicine in St. Louis, MO.

K. Frank Austen, M.D.: Dr. Austen is Astra Zeneca professor of respiratory and inflammatory diseases at Harvard Medical School and Brigham and Women’s Hospital.

Tim Goodship, M.D.: Dr. Goodship is professor of renal medicine at Newcastle University, UK.